227
Views
5
CrossRef citations to date
0
Altmetric
Articles

Inhibition of mushroom tyrosinase by a newly synthesized ligand: inhibition kinetics and computational simulations

, , , &
Pages 448-459 | Received 25 Nov 2011, Accepted 02 Mar 2012, Published online: 11 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Samaneh Zolghadri, Asieh Bahrami, Mahmud Tareq Hassan Khan, J. Munoz-Munoz, F. Garcia-Molina, F. Garcia-Canovas & Ali Akbar Saboury. (2019) A comprehensive review on tyrosinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 279-309.
Read now
Kowsar Bagherzadeh, Faezeh Shirgahi Talari, Amirhossein Sharifi, Mohammad Reza Ganjali, Ali Akbar Saboury & Massoud Amanlou. (2015) A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies. Journal of Biomolecular Structure and Dynamics 33:3, pages 487-501.
Read now

Articles from other publishers (3)

Rengasamy Sathya, Mariadhas Valan Arasu, Soundharrajan Ilavenil, T.S. Rejiniemon & Ponnuswamy Vijayaraghavan. (2023) Cosmeceutical potentials of litchi fruit and its by-products for a sustainable revalorization. Biocatalysis and Agricultural Biotechnology 50, pages 102683.
Crossref
Samaneh Zolghadri, Mohammad Beygi, Tasneem F. Mohammad, Mahdi Alijanianzadeh, Thanigaimalai Pillaiyar, Pablo Garcia-Molina, Francisco Garcia-Canovas, Jose Munoz-Munoz & Ali Akbar Saboury. (2023) Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises. Biochemical Pharmacology 212, pages 115574.
Crossref
Hanaa A. Galeb, Emma L. Wilkinson, Alison F. Stowell, Hungyen Lin, Samuel T. Murphy, Pierre L. Martin‐Hirsch, Richard L. Mort, Adam M. Taylor & John G. Hardy. (2020) Melanins as Sustainable Resources for Advanced Biotechnological Applications. Global Challenges 5:2, pages 2000102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.